Neogen

Neogen N.V. operates as a pharmaceutical out-licensing company headquartered in Anderlecht, Belgium. The firm is an integral part of the A.forall Group, a Belgian pharmaceutical conglomerate focused on the global development, manufacturing, and distribution of pharmaceutical products. Neogen's core business model is centered on the development, out-licensing, and long-term supply of generic pharmaceutical products to other companies. Revenue is generated through licensing agreements and the subsequent supply of these developed products. The company's strategy involves providing registration support and ensuring timely product launches for its partners, all while adhering to cGMP standards.

The company's portfolio covers a range of therapeutic areas, including oncology, anti-infectives, gastro-intestinal treatments, pain management, cardiology, and CNS. Products are either developed in-house, through sister companies within the A.forall Group, or via collaboration agreements with external developers. Neogen provides a diverse array of product formats, such as oral solids, injectables, nasal sprays, creams, and oral liquids. This model allows them to serve as a key supplier and development partner for a global client base of pharmaceutical companies seeking to broaden their generic drug offerings without undertaking the development process themselves.

As a key entity within the A.forall Group, Neogen contributes to the group's wider mission of distributing a broad spectrum of pharmaceutical products to pharmacies, wholesalers, hospitals, and retirement homes. The parent group employs over 144 individuals and is a global participant in the generics market, with an expanding pipeline of niche and complex products. Neogen itself is located at Square Marie Curie in Brussels and has expanded its facilities in Anderlecht to support growing operational capacity.

Keywords: generic pharmaceuticals, out-licensing, pharmaceutical development, B2B pharma, drug licensing, generic drugs, pharmaceutical supply, A.forall Group, Alter Pharma, Anderlecht pharmaceuticals, Belgium pharma, dosage form development, cGMP manufacturing, pharmaceutical business development, oncology generics, anti-infectives generics, cardiology generics, pain management generics, CNS generics, injectables development, oral solids development, nasal drug delivery, pharmaceutical registration support